J B Chemicals & Pharmaceuticals Results Earnings Call for Q2FY24
Conference Call with J B Chemicals & Pharmaceuticals Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript.08-11-2023
08-11-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper cutting of extract of consolidated financial results for the quarter and half year ended on September 30, 202308-11-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Disclosure Under Regulation 30
Disclosure under Regulation 3007-11-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of Equity shares on exercise of Stock options pursuant to the Employee Stock Scheme07-11-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement Under Regulation 30 - Grant Of Options Under Employee Stock Option Scheme
Grant of Options under Employee Stock Option Scheme07-11-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation07-11-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Disclosure Under Regulation 30- Amendment To The Employee Stock Option Scheme
Amendment to the Employee Stock Option Scheme07-11-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Non-Executive Director07-11-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors
Unaudited financial results for the quarter and half year ended on September 30, 2023 accompanied by limited review report07-11-2023